Redux Bio
PrivateLast Round
Seed
Nov 12, 2021
Total Funding Raised
$3M
Company Overview
Redux Bio is an aquaculture company that develops preventative disease management tools as sustainable alternatives to antibiotics for livestock and aquaculture farmers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redux Bio Comparables
Compare Redux Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ViAqua Therapeutics | 87% | |
| AquaNab Solutions | 76% | |
| Boehringer Ingelheim | 61% |
Redux Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2021 |
Redux Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genoa Ventures | Seed |
Redux Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Redux Bio's valuation, stock price, and market status.
Is Redux Bio a public or private company?
Redux Bio is a private company.
What is the current stock price of Redux Bio?
Redux Bio is a private company, so its shares have no public market price. Caplight tracks Redux Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Redux Bio worth (valuation)?
Valuation information for Redux Bio is not publicly available.
Can I buy Redux Bio stock?
Redux Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Redux Bio's last funding round?
Redux Bio's most recent funding round was Seed on November 12, 2021.
Who are the main investors in Redux Bio?
Key investors in Redux Bio include Genoa Ventures.
Will Redux Bio IPO soon?
No public IPO plans have been announced for Redux Bio.
How can I track Redux Bio secondary market activity?
Caplight tracks bids, offers, and trades in Redux Bio's shares on secondary markets.